319 related articles for article (PubMed ID: 22308486)
21. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma.
Scholl UI; Abriola L; Zhang C; Reimer EN; Plummer M; Kazmierczak BI; Zhang J; Hoyer D; Merkel JS; Wang W; Lifton RP
J Clin Invest; 2017 Jun; 127(7):2739-2750. PubMed ID: 28604387
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
[TBL] [Abstract][Full Text] [Related]
23. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
[TBL] [Abstract][Full Text] [Related]
24. Primary aldosteronism caused by a pI157S somatic
Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
[TBL] [Abstract][Full Text] [Related]
25. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
[TBL] [Abstract][Full Text] [Related]
26. KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
[TBL] [Abstract][Full Text] [Related]
27. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
Charmandari E; Sertedaki A; Kino T; Merakou C; Hoffman DA; Hatch MM; Hurt DE; Lin L; Xekouki P; Stratakis CA; Chrousos GP
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1532-9. PubMed ID: 22628607
[TBL] [Abstract][Full Text] [Related]
28. Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.
Scholl UI; Healy JM; Thiel A; Fonseca AL; Brown TC; Kunstman JW; Horne MJ; Dietrich D; Riemer J; Kücükköylü S; Reimer EN; Reis AC; Goh G; Kristiansen G; Mahajan A; Korah R; Lifton RP; Prasad ML; Carling T
Clin Endocrinol (Oxf); 2015 Dec; 83(6):779-89. PubMed ID: 26252618
[TBL] [Abstract][Full Text] [Related]
29. Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.
Vouillarmet J; Fernandes-Rosa F; Graeppi-Dulac J; Lantelme P; Decaussin-Petrucci M; Thivolet C; Peix JL; Boulkroun S; Clauser E; Zennaro MC
J Clin Endocrinol Metab; 2016 Nov; 101(11):3874-3878. PubMed ID: 27648962
[TBL] [Abstract][Full Text] [Related]
30.
Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
[TBL] [Abstract][Full Text] [Related]
31. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N
J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
[TBL] [Abstract][Full Text] [Related]
32. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
[TBL] [Abstract][Full Text] [Related]
33. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
[TBL] [Abstract][Full Text] [Related]
34. Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.
Maria AG; Suzuki M; Berthon A; Kamilaris C; Demidowich A; Lack J; Zilbermint M; Hannah-Shmouni F; Faucz FR; Stratakis CA
Am J Hypertens; 2020 Feb; 33(2):124-130. PubMed ID: 31637427
[TBL] [Abstract][Full Text] [Related]
35. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.
Arnesen T; Glomnes N; Strømsøy S; Knappskog S; Heie A; Akslen LA; Grytaas M; Varhaug JE; Gimm O; Brauckhoff M
Langenbecks Arch Surg; 2013 Aug; 398(6):869-74. PubMed ID: 23778974
[TBL] [Abstract][Full Text] [Related]
36. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
37. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
39. Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
Ono Y; Yamazaki Y; Omata K; Else T; Tomlins SA; Rhayem Y; Williams TA; Reincke M; Carling T; Monticone S; Mulatero P; Beuschlein F; Ito S; Satoh F; Rainey WE; Sasano H
J Clin Endocrinol Metab; 2020 Mar; 105(3):e282-9. PubMed ID: 31789380
[TBL] [Abstract][Full Text] [Related]
40. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
